Key result
Bone marrow chimeras with donors lacking AT1aR had more albuminuria and higher expression of inflammatory mediators, including MCP-1, with persistent macrophage infiltration in the kidney.
Answers are grounded in this paper and cite their sources.
AT1a receptors on bone marrow-derived cells appear to have protective actions against angiotensin II-induced renal inflammation and albuminuria.
We read with interest the article from Crowley et al,1 who studied the role of angiotensin II type 1 (AT1) receptors (AT1aR) on immune cells in the pathogenesis of angiotensin II–induced hypertension by generating bone marrow chimeras with wild-type (WT) donors or donors lacking AT1aR. Interestingly, they found that the group of donors lacking AT1aR had more albuminuria and higher expression of a number of inflammatory mediators, including monocyte chemoattractant protein 1 (MCP-1), with persistent infiltration of macrophages in the kidney, concluding that AT1aR on bone marrow–derived cells had protective actions.
No takes yet. Share an insight, caveat, or question.
Nahmod et al. (2010) conducted a letter in Angiotensin II-induced hypertension. Bone marrow chimeras with donors lacking AT1aR vs. Wild-type (WT) donors was evaluated on Albuminuria, expression of inflammatory mediators (including MCP-1), and macrophage infiltration in the kidney. Bone marrow chimeras with donors lacking AT1aR had more albuminuria and higher expression of inflammatory mediators, including MCP-1, with persistent macrophage infiltration in the kidney.
Synapse has enriched 10 related papers. Consider them for comparative context: